Organogenesis (ORGO) Short Interest Ratio & Short Volume → New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad) Free ORGO Stock Alerts $2.90 +0.04 (+1.40%) (As of 11:14 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Organogenesis Short Interest DataCurrent Short Volume7,230,000 sharesPrevious Short Volume8,010,000 sharesChange Vs. Previous Month-9.74%Dollar Volume Sold Short$20.53 millionShort Interest Ratio / Days to Cover9.4Last Record DateMarch 31, 2024Outstanding Shares131,960,000 sharesFloat Size77,320,000 sharesShort Percent of Float9.35%Today's Trading Volume74,752 sharesAverage Trading Volume753,639 sharesToday's Volume Vs. Average10% Short Selling Organogenesis ? Sign up to receive the latest short interest report for Organogenesis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatORGO Short Interest Over TimeORGO Days to Cover Over TimeORGO Percentage of Float Shorted Over Time Ad InvestorPlaceNew crypto project uncovers 2,050% in 65 daysDuring the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. Organogenesis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20247,230,000 shares $20.53 million -9.7%9.4%9.4 $2.84 3/15/20248,010,000 shares $22.83 million +5.8%10.3%11.5 $2.85 2/29/20247,570,000 shares $27.02 million +1.3%9.8%9.9 $3.57 2/15/20247,470,000 shares $27.49 million +11.3%9.4%10.2 $3.68 1/31/20246,710,000 shares $22.14 million +4.2%8.5%6.9 $3.30 1/15/20246,440,000 shares $25.24 million +56.7%8.2%6.6 $3.92 Get the Latest News and Ratings for ORGO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Organogenesis and its competitors with MarketBeat's FREE daily newsletter. 12/31/20234,110,000 shares $16.81 million -15.4%5.2%4.3 $4.09 12/15/20234,860,000 shares $18.23 million +4.1%6.2%5 $3.75 11/30/20234,670,000 shares $11.91 million -0.4%6.0%5.1 $2.55 11/15/20234,690,000 shares $11.87 million -1.7%6.0%5.4 $2.53 10/31/20234,770,000 shares $10.68 million +12.8%6.1%5 $2.24 10/15/20234,230,000 shares $9.98 million +8.2%5.4%5.1 $2.36 9/30/20233,910,000 shares $12.43 million +1.6%5.0%4.4 $3.18 9/15/20233,850,000 shares $9.43 million +25.8%4.9%4.5 $2.45 8/31/20233,060,000 shares $8.57 million +8.1%3.9%3.4 $2.80 8/15/20232,830,000 shares $7.58 million -16.5%3.6%2.8 $2.68 7/31/20233,390,000 shares $14.48 million -0.6%4.4%3.1 $4.27 7/15/20233,410,000 shares $13.30 million -7.3%5.1%3.2 $3.90 6/30/20233,680,000 shares $12.22 million -7.5%5.5%3.7 $3.32 6/15/20233,980,000 shares $16.36 million -14.0%5.9%3.8 $4.11 5/31/20234,630,000 shares $16.81 million -10.1%6.9%3.2 $3.63 5/15/20235,150,000 shares $16.38 million +0.8%7.7%3.5 $3.18 4/30/20235,110,000 shares $10.48 million +0.2%7.6%4 $2.05 4/15/20235,100,000 shares $10.56 million -1.5%7.6%4.1 $2.07 3/31/20235,180,000 shares $11.03 million -35.8%7.7%4.1 $2.13 3/15/20238,070,000 shares $17.43 million +1.3%12.1%6.5 $2.16 2/28/20237,970,000 shares $19.53 million +12.4%11.9%10 $2.45 2/15/20237,090,000 shares $20.70 million +12.2%10.2%10.7 $2.92 1/31/20236,320,000 shares $16.18 million +9.9%9.2%9.4 $2.56 1/15/20235,750,000 shares $14.89 million +2.0%8.4%9.2 $2.59 12/30/20225,640,000 shares $15.17 million +14.6%8.2%9.3 $2.69 12/15/20224,920,000 shares $12.50 million +4.9%7.8%8.1 $2.54 11/30/20224,690,000 shares $12.85 million -20.9%7.4%6.4 $2.74 11/15/20225,930,000 shares $17.02 million -0.7%9.3%6.9 $2.87 10/31/20225,970,000 shares $19.58 million +5.1%9.4%6.4 $3.28 10/15/20225,680,000 shares $18.18 million -1.1%9.0%5.7 $3.20 9/30/20225,740,000 shares $18.60 million -17.5%9.0%5.3 $3.24 9/15/20226,960,000 shares $24.78 million +7.4%11.0%5.9 $3.56 8/31/20226,480,000 shares $23.26 million +4.5%10.4%5.8 $3.59 8/15/20226,200,000 shares $30.19 million -16.9%9.9%5.8 $4.87New crypto project uncovers 2,050% in 65 days (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. ORGO Short Interest - Frequently Asked Questions What is Organogenesis' current short interest? Short interest is the volume of Organogenesis shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 7,230,000 shares of ORGO short. 9.35% of Organogenesis' shares are currently sold short. Learn More on Organogenesis' current short interest. What is a good short interest ratio for Organogenesis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ORGO shares currently have a short interest ratio of 9.0. Learn More on Organogenesis's short interest ratio. Which institutional investors are shorting Organogenesis? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Organogenesis: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Organogenesis? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.35% of Organogenesis' floating shares are currently sold short. Is Organogenesis' short interest increasing or decreasing? Organogenesis saw a decrease in short interest in March. As of March 31st, there was short interest totaling 7,230,000 shares, a decrease of 9.7% from the previous total of 8,010,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Organogenesis' float size? Organogenesis currently has issued a total of 131,960,000 shares. Some of Organogenesis' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Organogenesis currently has a public float of 77,320,000 shares. How does Organogenesis' short interest compare to its competitors? 9.35% of Organogenesis' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Organogenesis: Nkarta, Inc. (9.81%), Amarin Co. plc (4.39%), Adlai Nortye Ltd. (0.02%), ADC Therapeutics SA (1.81%), Esperion Therapeutics, Inc. (11.82%), Revance Therapeutics, Inc. (13.00%), Atai Life Sciences (4.81%), Nature's Sunshine Products, Inc. (0.60%), PepGen Inc. (1.48%), Rani Therapeutics Holdings, Inc. (16.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Organogenesis stock? Short selling ORGO is an investing strategy that aims to generate trading profit from Organogenesis as its price is falling. ORGO shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Organogenesis? A short squeeze for Organogenesis occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ORGO, which in turn drives the price of the stock up even further. How often is Organogenesis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORGO, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: NKTX Short Interest Data AMRN Short Interest Data ANL Short Interest Data ADCT Short Interest Data ESPR Short Interest Data RVNC Short Interest Data ATAI Short Interest Data NATR Short Interest Data PEPG Short Interest Data RANI Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORGO) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden’s $374B Giveaway Into This SectorDTIThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesMy biggest AI fearParadigm PressHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing